Becton Dickinson - 52 Year Stock Price History | BDX

Historical daily share price chart and data for Becton Dickinson since 1973 adjusted for splits and dividends. The latest closing stock price for Becton Dickinson as of April 30, 2025 is 207.09.
  • The all-time high Becton Dickinson stock closing price was 275.52 on July 27, 2023.
  • The Becton Dickinson 52-week high stock price is 251.99, which is 21.7% above the current share price.
  • The Becton Dickinson 52-week low stock price is 193.03, which is 6.8% below the current share price.
  • The average Becton Dickinson stock price for the last 52 weeks is 230.56.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Becton Dickinson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 224.7546 225.4640 247.9520 196.6100 207.0900 -8.30%
2024 231.6798 240.2320 243.1990 217.9880 225.8420 -5.38%
2023 246.4082 247.0340 275.5220 222.3700 238.6750 -2.67%
2022 238.2428 234.9670 262.8280 209.7200 245.2210 5.08%
2021 228.6386 229.4930 243.0790 218.0660 233.3610 1.88%
2020 225.0366 246.1590 258.3070 181.7650 229.0530 -6.75%
2019 221.9215 196.3390 247.0170 188.4170 245.6450 22.20%
2018 208.9317 191.8720 235.1070 186.1320 201.0140 6.61%
2017 170.3300 143.3130 200.3170 143.0090 188.5420 31.24%
2016 140.9569 126.2860 156.8460 113.4230 143.6600 9.22%
2015 121.7161 117.3660 133.6100 110.8280 131.5270 12.63%
2014 99.1616 89.9267 118.0300 86.8451 116.7790 28.27%
2013 79.9041 64.1195 91.1296 64.1195 91.0390 44.27%
2012 60.7941 58.6294 63.8612 57.1829 63.1026 7.24%
2011 62.3895 65.3167 69.8740 55.3930 58.8420 -9.69%
2010 57.2842 59.3691 65.7715 51.0325 65.1548 9.38%
2009 51.7101 51.7389 60.2150 45.0243 59.5655 17.60%
2008 59.5787 63.3021 67.3578 44.3950 50.6502 -16.92%
2007 56.5466 50.7028 62.0080 50.2852 60.9679 20.73%
2006 46.8755 42.9374 52.9434 41.7078 50.5012 18.34%
2005 39.4786 39.2588 43.1292 35.4335 42.6746 7.19%
2004 34.7723 28.4089 40.5345 28.4089 39.8125 39.77%
2003 24.9789 21.5779 28.6997 20.1480 28.4851 35.67%
2002 22.3961 22.5082 26.0801 16.9999 20.9964 -6.32%
2001 23.2817 22.8619 26.0801 20.2103 22.4135 -3.20%
2000 18.9476 17.2957 23.4888 14.9198 23.1545 30.15%
1999 21.0293 28.0859 28.0859 16.0161 17.7911 -36.19%
1998 24.4275 16.1963 30.5556 16.0344 27.8817 72.15%
1997 15.7665 13.8834 17.7774 13.8834 16.1963 16.66%
1996 13.1423 11.9866 14.3596 11.3762 13.8834 16.98%
1995 9.2784 7.5293 11.9502 7.5293 11.8679 58.45%
1994 6.4341 5.4959 7.7243 5.2470 7.4902 36.76%
1993 5.5754 5.8450 6.0683 4.9467 5.4768 -7.34%
1992 5.4894 4.9078 6.2804 4.8616 5.9108 16.70%
1991 5.1760 5.4344 5.8846 4.2947 5.0650 -6.48%
1990 4.7453 4.4785 5.5252 4.0136 5.4162 22.41%
1989 3.9243 3.5998 4.4248 3.4405 4.4248 21.14%
1988 3.7692 3.5590 4.2737 3.2595 3.6525 3.63%
1987 3.9886 3.4497 4.6974 3.0431 3.5244 3.44%
1986 3.2224 2.0951 4.1203 2.0951 3.4071 63.61%
1985 1.7444 1.3051 2.1874 1.3051 2.0825 60.07%
1984 1.1638 1.2000 1.3277 0.9980 1.3010 11.37%
1983 1.3527 1.3388 1.6758 1.1046 1.1682 -11.71%
1982 1.3402 1.4944 1.5489 1.1286 1.3232 -10.99%
1981 1.4369 1.6462 1.6773 1.1792 1.4866 -8.61%
1980 1.1677 1.0352 1.6267 0.8406 1.6267 53.68%
1979 1.0283 0.9885 1.1325 0.8523 1.0585 8.80%
1978 1.1393 0.9807 1.2726 0.9457 0.9729 -0.80%
1977 0.9330 1.0624 1.0819 0.8056 0.9807 -6.66%
1976 1.1645 1.2259 1.3154 1.0118 1.0507 -13.47%
1975 1.0873 0.8990 1.2376 0.8990 1.2142 41.81%
1974 0.9841 1.1675 1.2414 0.6538 0.8562 -26.66%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $59.276B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.641B 24.25
Cardinal Health (CAH) United States $33.781B 18.09
Labcorp (LH) United States $20.116B 16.32
Straumann Holding AG (SAUHY) Switzerland $19.852B 0.00
Cooper (COO) United States $16.444B 21.81
West Pharmaceutical Services (WST) United States $15.336B 32.15
Align Technology (ALGN) United States $13.013B 25.21
Henry Schein (HSIC) United States $8.105B 13.96
Merit Medical Systems (MMSI) United States $5.600B 27.07
DENTSPLY SIRONA (XRAY) United States $2.780B 8.35
CONMED (CNMD) United States $1.583B 12.30
STAAR Surgical (STAA) United States $0.918B 0.00
Pro-Dex (PDEX) United States $0.217B 33.03
Lifevantage (LFVN) United States $0.155B 17.15